期刊
HEMATOLOGICAL ONCOLOGY
卷 40, 期 4, 页码 805-808出版社
WILEY
DOI: 10.1002/hon.2985
关键词
accelerated phase; BCL2 inhibitor; chronic lymphocytic leukemia; targeted therapies